Today, Lilly announced caps on out-of-pocket insulin costs at $35 per month and price reductions of 70% for its most commonly prescribed insulins.
In addition, according to their website announcement, Lilly is reducing the list price of insulins:
“The aggressive price cuts we’re announcing today should make a real difference for Americans with diabetes. Because these price cuts will take time for the insurance and pharmacy system to implement, we are taking the additional step to immediately cap out-of-pocket costs for patients who use Lilly insulin and are not covered by the recent Medicare Part D cap” said David A. Ricks, Lilly’s Chair and CEO.
“The American Diabetes Association (ADA) is the leading voice advocating for insulin affordability and is working to ensure that all people with diabetes have access to the care they need. We applaud Eli Lilly for taking the important step to limit cost-sharing for its insulin, and we encourage other insulin manufacturers to do the same. While we have been able to help achieve significant progress on the issue of insulin affordability, including Medicare’s new out-of-pocket cost cap on insulin, state copay caps, and patient assistance developments from insulin manufacturers, we know that our work is not done. We will work to ensure that Eli Lilly’s patient assistance program is benefiting patients as intended and continue the fight so that everyone who needs insulin has access.”? — Charles “Chuck” Henderson, CEO of the American Diabetes Association
Insulin has grown increasingly expensive in recent years despite the introduction of new competition. Many people with diabetes ration their medicines or discontinue them because of the cost. More than 30 million Americans live with diabetes, and more than seven million of them rely on insulin.
Click here to learn more and get involved!
Read our blog here for more info
August 4, 2023 – 3:20 pm
Keynote: Revitalize your Diabetes Program or Business with Proven Strategies
October 11, 2023 – 8:00 am
March 30, 2023 – 11:30 am
April 6, 2023 – 11:30 am
FREE Preparing for the BC-ADM Exam Webinar – What you need to know
April 11, 2023 – 11:30 am
Level 2 | Microvascular Complications, Eye, Kidney & Nerve Disease Standards | 1.5 CEs
April 26, 2023 – 8:00 am
Virtual DiabetesEd Training Conference | April 26-28th | 30+ CEs
July 19, 2023 – 9:00 am
July 26, 2023 – 9:00 am